These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2605571)

  • 1. Presence of a receptor for the active component of Iscador in ascites fluid of tumour bearing mice.
    Kuttan G; Vasudevan DM; Kuttan R
    Cancer Lett; 1989 Dec; 48(3):223-7. PubMed ID: 2605571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).
    Kuttan G; Vasudevan DM; Kuttan R
    Cancer Lett; 1988 Aug; 41(3):307-14. PubMed ID: 3409209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
    Kuttan G; Vasudevan DM; Kuttan R
    J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lung metastasis by adoptive immunotherapy using Iscador.
    Antony S; Kuttan R; Kuttan G
    Immunol Invest; 1999 Jan; 28(1):1-8. PubMed ID: 10073677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
    Kuttan G; Menon LG; Kuttan R
    Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natural killer cells in iscador mediated inhibition of metastasis by adoptive immunotherapy.
    Antony S; Kuttan R; Kuttan G
    Immunol Invest; 2000 Aug; 29(3):219-31. PubMed ID: 10933606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the tumor-inhibiting efficacy of Iscador in experimental animal tumors.
    Berger M; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(3):262-5. PubMed ID: 6853588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticarcinogenic and antimetastatic activity of Iscador.
    Kuttan G; Menon LG; Antony S; Kuttan R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
    Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
    Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R; Sandvig K; Olsnes S
    Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concanavalin A and wheat germ agglutinin receptors in the ascitic fluid of rat hepatomas.
    Neri G; Hayes SP; Smith HW; Capetillo S; Walborg EF
    Tumori; 1979 Feb; 65(1):9-18. PubMed ID: 442222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
    Kelter G; Fiebig HH
    Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
    Maldacker J
    Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
    Maier G; Fiebig HH
    Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iscador update: interview with Robert Gorter, M.D. Interview by Fred Gardner.
    Gorter R
    AIDS Treat News; 1998 Oct; (No 304):7-8 contd. PubMed ID: 11365865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iscador.
    CA Cancer J Clin; 1983; 33(3):186-8. PubMed ID: 6404528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.